These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 9463786)

  • 1. Combined opioid-NMDA antagonist therapies. What advantages do they offer for the control of pain syndromes?
    Wiesenfeld-Hallin Z
    Drugs; 1998 Jan; 55(1):1-4. PubMed ID: 9463786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ketamine in cancer pain: an update.
    Mercadante S
    Palliat Med; 1996 Jul; 10(3):225-30. PubMed ID: 8817593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of N-methyl-D-aspartate receptor antagonists on acute morphine-induced and l-methadone-induced antinociception in mice.
    Fischer BD; Carrigan KA; Dykstra LA
    J Pain; 2005 Jul; 6(7):425-33. PubMed ID: 15993820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A qualitative systematic review of the role of N-methyl-D-aspartate receptor antagonists in preventive analgesia.
    McCartney CJ; Sinha A; Katz J
    Anesth Analg; 2004 May; 98(5):1385-400, table of contents. PubMed ID: 15105220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The importance of the number of NMDA receptors in the development of supersensitivity or tolerance to and dependence on morphine.
    Koyuncuoglu H; Nurten A; Yamantürk P; Nurten R
    Pharmacol Res; 1999 Apr; 39(4):311-9. PubMed ID: 10208762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complete prevention but stimulus-dependent reversion of morphine tolerance by the glycine/NMDA receptor antagonist (+)-HA966 in neuropathic rats.
    Christensen D; Guilbaud G; Kayser V
    Anesthesiology; 2000 Mar; 92(3):786-94. PubMed ID: 10719957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of NMDA-receptor antagonists in the treatment of chronic pain.
    Hewitt DJ
    Clin J Pain; 2000 Jun; 16(2 Suppl):S73-9. PubMed ID: 10870744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ketamine, an NMDA receptor antagonist, suppresses spatial and temporal properties of burn-induced secondary hyperalgesia in man: a double-blind, cross-over comparison with morphine and placebo.
    Warncke T; Stubhaug A; Jørum E
    Pain; 1997 Aug; 72(1-2):99-106. PubMed ID: 9272793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolonged analgesic effect of ketamine, an N-methyl-D-aspartate receptor inhibitor, in patients with chronic pain.
    Rabben T; Skjelbred P; Oye I
    J Pharmacol Exp Ther; 1999 May; 289(2):1060-6. PubMed ID: 10215688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low dose ketamine: a therapeutic and research tool to explore N-methyl-D-aspartate (NMDA) receptor-mediated plasticity in pain pathways.
    Chizh BA
    J Psychopharmacol; 2007 May; 21(3):259-71. PubMed ID: 17591654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NMDA-receptor antagonists in neuropathic pain: experimental methods to clinical trials.
    Sang CN
    J Pain Symptom Manage; 2000 Jan; 19(1 Suppl):S21-5. PubMed ID: 10687335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The antinociceptive effect of combined systemic administration of morphine and the glycine/NMDA receptor antagonist, (+)-HA966 in a rat model of peripheral neuropathy.
    Christensen D; Idänpään-Heikkilä JJ; Guilbaud G; Kayser V
    Br J Pharmacol; 1998 Dec; 125(8):1641-50. PubMed ID: 9886755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Large-dose oral dextromethorphan as an adjunct to patient-controlled analgesia with morphine after knee surgery.
    Wadhwa A; Clarke D; Goodchild CS; Young D
    Anesth Analg; 2001 Feb; 92(2):448-54. PubMed ID: 11159249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacotherapy for acute postoperative pain based on use of NMDA receptors-associated drugs].
    Ovechkin AM; Efremenko IV
    Anesteziol Reanimatol; 2013; (3):63-9. PubMed ID: 24341000
    [No Abstract]   [Full Text] [Related]  

  • 15. N-methyl-D-aspartate receptor antagonists potentiate the antinociceptive effects of morphine in squirrel monkeys.
    Allen RM; Dykstra LA
    J Pharmacol Exp Ther; 2001 Jul; 298(1):288-97. PubMed ID: 11408554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Low doses ketamine: antihyperalgesic drug, non-analgesic].
    Richebé P; Rivat C; Rivalan B; Maurette P; Simonnet G
    Ann Fr Anesth Reanim; 2005; 24(11-12):1349-59. PubMed ID: 16115745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Development of opioid tolerance -- molecular mechanisms and clinical consequences].
    Freye E; Latasch L
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2003 Jan; 38(1):14-26. PubMed ID: 12522725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effects of MPEP, an mGluR5 antagonist, and memantine, an N-methyl-D-aspartate receptor antagonist, on morphine antinociceptive tolerance in mice.
    Kozela E; Pilc A; Popik P
    Psychopharmacology (Berl); 2003 Jan; 165(3):245-51. PubMed ID: 12442203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined systemic administration of the glycine/NMDA receptor antagonist, (+)-HA966 and morphine attenuates pain-related behaviour in a rat model of trigeminal neuropathic pain.
    Christensen D; Gautron M; Guilbaud G; Kayser V
    Pain; 1999 Dec; 83(3):433-440. PubMed ID: 10568851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [NMDA-receptor antagonist in pain therapy].
    Weber C
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1998 Aug; 33(8):475-83. PubMed ID: 9746842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.